Form 4: Hims & Hers Health Chief Legal Officer Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,335 shares of Class A Common Stock at a price of $20.29 per share on July 23, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- On July 23, 2024, Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., sold 2,335 shares of Class A Common Stock.
- The sale was executed at a price of $20.29 per share.
- Following the transaction, Boughton directly owns 166,809 shares of Hims & Hers Health, Inc.
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on September 10, 2023.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing for an insider stock sale under a pre-arranged plan, indicating a neutral sentiment.
Industry Context
Insider sales are a common occurrence, and the use of a 10b5-1 plan suggests the sale was pre-planned and not based on any specific non-public information.
Stakeholder Impact
- The sale of shares by a company executive could be perceived negatively by some investors, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 2023-09-10 | Date of adoption of the Rule 10b5-1 trading plan. |
| 2024-07-23 | Date of the transaction (sale of shares). |
| 2024-07-25 | Date of signature of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.